Frailty and Cancer: Current Perspectives on Assessment and Monitoring

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2023 Apr 4

PMID 37013130

Authors

Valentin Goede

Affiliations

Soon will be listed here.

Abstract

Frailty, an age-related condition of increased vulnerability to acute endogenous or exogenous stressors, is a key barrier to successful treatment of cancer in older people. In this group of patients, assessment of frailty is required before starting a new treatment. According to guidelines, the gold standard to assess frailty in older adults with cancer is geriatric screening followed by geriatric assessment (GA) across essential GA-domains (social status, physical function, nutrition, cognition, emotion, co-morbidity, polypharmacy). GA enables tailoring of both oncological therapy and non-oncological interventions to the patient's vulnerabilities. Large clinical trials recently have demonstrated that the feasibility and tolerability of systemic cancer treatment in older patients are significantly improved by such GA-guided management. Indications and optimal tools for frailty monitoring during the course of cancer treatment have not yet been defined in greater detail. New technologies such as wearable sensors or apps offer promising new opportunities to further develop frailty monitoring. This review describes the current standards and perspectives for the assessment and monitoring of frailty in elderly patients with cancer.

Citing Articles

Management of lung cancer in older adults.

Stieglitz S, Goede V, Schlesinger A Z Gerontol Geriatr. 2025; 58(2):103-108.

PMID: 39971759 DOI: 10.1007/s00391-025-02412-w.

Digital humanistic program to manage premature frailty in young breast cancer survivors with gender perspective.

Hu Y, Wiley J, Jiang L, Wang X, Yi R, Xu J NPJ Digit Med. 2025; 8(1):35.

PMID: 39820349 PMC: 11739469. DOI: 10.1038/s41746-025-01439-y.

Risk assessment and predictive modeling of suicide in multiple myeloma patients.

Shen J, Lin S, Tao H, Sechi L, Fozza C, Wen X J Cancer Surviv. 2024; .

PMID: 39688626 DOI: 10.1007/s11764-024-01732-x.

Genetically predicted frailty index and risk of cutaneous melanoma: a two-sample Mendelian randomization study.

Zhou Z, Cui C, Yuan Y, Ma Z Arch Dermatol Res. 2024; 317(1):119.

PMID: 39673608 DOI: 10.1007/s00403-024-03593-x.

Han W, Sazzad H, Bloch M, Baker D, Roth N, Bowden-Reid E Cell Rep Med. 2024; 5(12):101835.

PMID: 39626674 PMC: 11722090. DOI: 10.1016/j.xcrm.2024.101835.

References

Puts M, Hardt J, Monette J, Girre V, Springall E, Alibhai S . Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst. 2012; 104(15):1133-63. PMC: 3413614. DOI: 10.1093/jnci/djs285. View

Kastora S, Kounidas G, Perrott S, Carter B, Hewitt J, Myint P . Clinical frailty scale as a point of care prognostic indicator of mortality in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021; 36:100896. PMC: 8141355. DOI: 10.1016/j.eclinm.2021.100896. View

Lawton M, Brody E . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9(3):179-86. View

Clegg A, Young J, Iliffe S, Rikkert M, Rockwood K . Frailty in elderly people. Lancet. 2013; 381(9868):752-62. PMC: 4098658. DOI: 10.1016/S0140-6736(12)62167-9. View

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

Karnakis T, Gattas-Vernaglia I, Saraiva M, Gil-Junior L, Kanaji A, Jacob-Filho W . The geriatrician's perspective on practical aspects of the multidisciplinary care of older adults with cancer. J Geriatr Oncol. 2016; 7(5):341-5. DOI: 10.1016/j.jgo.2016.07.001. View

Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6):649-55. View

Bellera C, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M . Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012; 23(8):2166-2172. DOI: 10.1093/annonc/mdr587. View

Narasimhulu D, McGree M, Weaver A, Jatoi A, LeBrasseur N, Glaser G . Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer. Gynecol Oncol. 2020; 158(3):646-652. DOI: 10.1016/j.ygyno.2020.05.046. View

10.

van Walree I, Scheepers E, van Huis-Tanja L, Emmelot-Vonk M, Bellera C, Soubeyran P . A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol. 2019; 10(6):847-858. DOI: 10.1016/j.jgo.2019.04.016. View

11.

Hamaker M, Jonker J, de Rooij S, Vos A, Smorenburg C, van Munster B . Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012; 13(10):e437-44. DOI: 10.1016/S1470-2045(12)70259-0. View

12.

Ethun C, Bilen M, Jani A, Maithel S, Ogan K, Master V . Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017; 67(5):362-377. DOI: 10.3322/caac.21406. View

13.

Ferrucci L, Fabbri E . Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018; 15(9):505-522. PMC: 6146930. DOI: 10.1038/s41569-018-0064-2. View

14.

Podsiadlo D, Richardson S . The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39(2):142-8. DOI: 10.1111/j.1532-5415.1991.tb01616.x. View

15.

Le Saux O, Falandry C, Gan H, You B, Freyer G, Peron J . Changes in the use of end points in clinical trials for elderly cancer patients over time. Ann Oncol. 2017; 28(10):2606-2611. DOI: 10.1093/annonc/mdx354. View

16.

Ortland I, Mendel Ott M, Kowar M, Sippel C, Jaehde U, Jacobs A . Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer. J Geriatr Oncol. 2020; 11(6):997-1005. DOI: 10.1016/j.jgo.2019.12.016. View

17.

Rockwood K, Song X, MacKnight C, Bergman H, Hogan D, McDowell I . A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005; 173(5):489-95. PMC: 1188185. DOI: 10.1503/cmaj.050051. View

18.

Jolly T, Deal A, Nyrop K, Williams G, Pergolotti M, Wood W . Geriatric assessment-identified deficits in older cancer patients with normal performance status. Oncologist. 2015; 20(4):379-85. PMC: 4391761. DOI: 10.1634/theoncologist.2014-0247. View

19.

Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen M, Extermann M . International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014; 32(24):2595-603. PMC: 4876338. DOI: 10.1200/JCO.2013.54.8347. View

20.

McCusker J, Bellavance F, Cardin S, Trepanier S . Screening for geriatric problems in the emergency department: reliability and validity. Identification of Seniors at Risk (ISAR) Steering Committee. Acad Emerg Med. 1998; 5(9):883-93. DOI: 10.1111/j.1553-2712.1998.tb02818.x. View